$8.00
Purpose: Stimulates bowel movement; treats constipation by increasing intestinal motility.
Description
Picolax (sodium picosulfate) Oral Drops 0.75% 15 ml Vial
Ingredients
Active ingredient: Sodium picosulfate.
Other ingredients: [List other ingredients if applicable].
Dosage
Recommended dosage: Consult your healthcare provider for the appropriate dosage instructions.
Do not exceed the recommended dose.
Indications
Picolax oral drops are indicated for the relief of constipation and to prepare the bowel for diagnostic procedures.
Contraindications
Do not use Picolax oral drops if:
- You are allergic to any of the ingredients.
- You have severe dehydration.
- You have a blockage in your intestines.
Directions
For oral use only.
Shake the vial before use. Follow the instructions provided by your healthcare provider for the correct dosage and administration.
Scientific Evidence
There is scientific evidence supporting the efficacy of sodium picosulfate in promoting bowel movements and relieving constipation. Studies have shown that sodium picosulfate acts locally in the colon to stimulate bowel motility, leading to improved bowel function.
Additional Information
Picolax oral drops are well-tolerated by most individuals when used as directed. It is important to drink plenty of fluids while using this medication to prevent dehydration. If you experience any severe side effects or have concerns about using Picolax, consult your healthcare provider.
Pharmacological Effects
Sodium picosulfate is a stimulant laxative that works by increasing the movement of the intestines, promoting bowel movements. It acts by stimulating the nerve endings in the intestinal mucosa, leading to enhanced colonic peristalsis and ultimately facilitating the passage of stool.
Clinical Trials and Comparative Effectiveness
Clinical trials have demonstrated the effectiveness of sodium picosulfate in treating constipation and preparing the bowel for procedures. Compared to other laxatives, sodium picosulfate has shown comparable efficacy with a favorable safety profile, making it a preferred choice in clinical practice.
References:
1. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100(1):232-242.
2. Tack J, Müller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009;7(5):502-508.
Recent Reviews